ES2027728T3 - Procedimiento para hacer un injerto que se ha de usar para actila cicatrizacion de un tejido. - Google Patents
Procedimiento para hacer un injerto que se ha de usar para actila cicatrizacion de un tejido.Info
- Publication number
- ES2027728T3 ES2027728T3 ES198888109803T ES88109803T ES2027728T3 ES 2027728 T3 ES2027728 T3 ES 2027728T3 ES 198888109803 T ES198888109803 T ES 198888109803T ES 88109803 T ES88109803 T ES 88109803T ES 2027728 T3 ES2027728 T3 ES 2027728T3
- Authority
- ES
- Spain
- Prior art keywords
- tissue
- healing
- actile
- graft
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Transplantation (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
Abstract
LA CICATRIZACION DE UN TEJIDO AVASCULAR HERIDO, SE PROMUEVE APLICANDO UN FACTOR ANGIOGENICO EN LA PROXIMIDAD DEL TEJIDO HERIDO EN FORMA DE UNA IMPLANTACION.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/064,215 US4952404A (en) | 1987-06-19 | 1987-06-19 | Promotion of healing of meniscal tissue |
US07/204,097 US4952403A (en) | 1987-06-19 | 1988-06-08 | Implants for the promotion of healing of meniscal tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2027728T3 true ES2027728T3 (es) | 1992-06-16 |
Family
ID=26744280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198888109803T Expired - Lifetime ES2027728T3 (es) | 1987-06-19 | 1988-06-20 | Procedimiento para hacer un injerto que se ha de usar para actila cicatrizacion de un tejido. |
Country Status (11)
Country | Link |
---|---|
US (1) | US4952403A (es) |
EP (1) | EP0295721B1 (es) |
JP (1) | JPS6486974A (es) |
KR (1) | KR910005886B1 (es) |
AU (1) | AU605599B2 (es) |
CA (1) | CA1326817C (es) |
DE (1) | DE3867328D1 (es) |
DK (1) | DK333788A (es) |
ES (1) | ES2027728T3 (es) |
GR (1) | GR3004229T3 (es) |
PT (1) | PT87753B (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015586A2 (en) * | 1989-06-05 | 1990-12-27 | Massachusetts Institute Of Technology | Bioerodible polymers for drug delivery in bone |
US6054122A (en) * | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US7189410B1 (en) | 1990-11-27 | 2007-03-13 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US6559119B1 (en) | 1990-11-27 | 2003-05-06 | Loyola University Of Chicago | Method of preparing a tissue sealant-treated biomedical material |
EP1142581A3 (en) * | 1990-11-27 | 2002-09-11 | American National Red Cross | Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
US6117425A (en) * | 1990-11-27 | 2000-09-12 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, method of their production and use |
US6197325B1 (en) * | 1990-11-27 | 2001-03-06 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US5206023A (en) * | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
US5201728A (en) * | 1991-05-03 | 1993-04-13 | Giampapa Vincent C | Subcutaneous implantable multiple-agent delivery system |
US5326568A (en) * | 1991-05-03 | 1994-07-05 | Giampapa Vincent C | Method of tissue-specific delivery |
CA2071137A1 (en) * | 1991-07-10 | 1993-01-11 | Clarence C. Lee | Composition and method for revitalizing scar tissue |
US5270300A (en) * | 1991-09-06 | 1993-12-14 | Robert Francis Shaw | Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
US5583114A (en) | 1994-07-27 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
USRE38827E1 (en) | 1994-07-27 | 2005-10-11 | 3M Innovative Properties Company | Adhesive sealant composition |
US5660848A (en) * | 1994-11-02 | 1997-08-26 | The Population Council, Center For Biomedical Research | Subdermally implantable device |
US6107102A (en) * | 1995-06-07 | 2000-08-22 | Regents Of The University Of California | Therapeutic microdevices and methods of making and using same |
US6762336B1 (en) | 1998-01-19 | 2004-07-13 | The American National Red Cross | Hemostatic sandwich bandage |
DE19841698A1 (de) * | 1998-09-11 | 2000-03-16 | Curative Technologies Gmbh | Wachstumsfaktor-enthaltende Zusammensetzung zur Heilung von Gewebeschäden |
US6964685B2 (en) | 1999-06-22 | 2005-11-15 | The Brigham And Women's Hospital, Inc. | Biologic replacement for fibrin clot |
AU5754800A (en) * | 1999-06-22 | 2001-01-09 | Brigham And Women's Hospital | Biologic replacement for fibrin clot for intra-articular use |
US20040241211A9 (en) * | 2000-11-06 | 2004-12-02 | Fischell Robert E. | Devices and methods for reducing scar tissue formation |
US6534693B2 (en) * | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
US20040018228A1 (en) * | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
US6648911B1 (en) | 2000-11-20 | 2003-11-18 | Avantec Vascular Corporation | Method and device for the treatment of vulnerable tissue site |
GB0113697D0 (en) * | 2001-06-06 | 2001-07-25 | Smith & Nephew | Fixation devices for tissue repair |
CN1327905C (zh) | 2002-09-10 | 2007-07-25 | 美国国家红十字会 | 止血敷料 |
EP2338442B1 (en) | 2003-12-11 | 2013-01-30 | Isto Technologies Inc. | Particulate cartilage system |
EP1781264B1 (en) | 2004-08-04 | 2013-07-24 | Evonik Corporation | Methods for manufacturing delivery devices and devices thereof |
US8480757B2 (en) | 2005-08-26 | 2013-07-09 | Zimmer, Inc. | Implants and methods for repair, replacement and treatment of disease |
AU2007208243B2 (en) | 2006-01-25 | 2013-09-19 | Children's Medical Center Corporation | Methods and procedures for ligament repair |
US20080033333A1 (en) * | 2006-08-04 | 2008-02-07 | Macphee Martin | Solid dressing for treating wounded tissue |
AU2007320018B2 (en) | 2006-09-28 | 2014-03-06 | Children's Medical Center Corporation | Methods and collagen products for tissue repair |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
WO2008128075A1 (en) | 2007-04-12 | 2008-10-23 | Isto Technologies, Inc. | Compositions and methods for tissue repair |
WO2009020612A1 (en) * | 2007-08-06 | 2009-02-12 | Stb Lifesaving Technologies, Inc. | Methods and dressing for sealing internal injuries |
EP2222281B1 (en) | 2007-12-20 | 2018-12-05 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
WO2013116744A1 (en) | 2012-02-01 | 2013-08-08 | Children's Medical Center Corporation | Biomaterial for articular cartilage maintenance and treatment of arthritis |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
EP2951193A4 (en) | 2013-02-01 | 2017-03-01 | Children's Medical Center Corporation | Collagen scaffolds |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4450150A (en) * | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
US4391797A (en) * | 1977-01-05 | 1983-07-05 | The Children's Hospital Medical Center | Systems for the controlled release of macromolecules |
SE416175B (sv) * | 1979-03-07 | 1980-12-08 | Per Ingvar Branemark | For implantering i kroppsvevnad serskilt benvevnad, avsett material |
US4529590A (en) * | 1982-12-27 | 1985-07-16 | Leveen Robert F | Production of angiogenetic factor |
US4503038A (en) * | 1983-02-25 | 1985-03-05 | The Regents Of The University Of California | Extracellular nonmitogenic angiogenesis factor and method of isolation thereof from wound fluid |
US4690682A (en) * | 1983-04-15 | 1987-09-01 | Damon Biotech, Inc. | Sustained release |
GB8330969D0 (en) * | 1983-11-21 | 1983-12-29 | Wellcome Found | Promoting healing |
IL74715A0 (en) * | 1984-03-27 | 1985-06-30 | Univ New Jersey Med | Biodegradable matrix and methods for producing same |
US4699788A (en) * | 1984-08-20 | 1987-10-13 | Trustees Of Boston University | Angiogenic factor methods of extraction and method for producing angiogenesis |
US4727137A (en) * | 1985-04-17 | 1988-02-23 | President And Fellows Of Harvard College | Purified protein having angiogenic activity and methods of preparation |
JPH0664019B2 (ja) * | 1985-07-16 | 1994-08-22 | 株式会社日立製作所 | 画像表示処理装置 |
AU695983B3 (en) * | 1997-09-19 | 1998-08-27 | Badge Company (Proprietary) Limited, The | Badge and method of making it |
-
1988
- 1988-06-08 US US07/204,097 patent/US4952403A/en not_active Expired - Lifetime
- 1988-06-16 CA CA000569621A patent/CA1326817C/en not_active Expired - Fee Related
- 1988-06-17 PT PT87753A patent/PT87753B/pt not_active IP Right Cessation
- 1988-06-17 AU AU18117/88A patent/AU605599B2/en not_active Ceased
- 1988-06-17 DK DK333788A patent/DK333788A/da not_active Application Discontinuation
- 1988-06-18 KR KR1019880007369A patent/KR910005886B1/ko not_active IP Right Cessation
- 1988-06-20 DE DE8888109803T patent/DE3867328D1/de not_active Expired - Lifetime
- 1988-06-20 ES ES198888109803T patent/ES2027728T3/es not_active Expired - Lifetime
- 1988-06-20 EP EP88109803A patent/EP0295721B1/en not_active Expired - Lifetime
- 1988-06-20 JP JP63150381A patent/JPS6486974A/ja active Granted
-
1992
- 1992-04-01 GR GR920400601T patent/GR3004229T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0295721B1 (en) | 1992-01-02 |
PT87753A (pt) | 1988-07-01 |
DK333788A (da) | 1989-02-10 |
JPS6486974A (en) | 1989-03-31 |
EP0295721A2 (en) | 1988-12-21 |
US4952403A (en) | 1990-08-28 |
AU605599B2 (en) | 1991-01-17 |
CA1326817C (en) | 1994-02-08 |
GR3004229T3 (es) | 1993-03-31 |
PT87753B (pt) | 1992-10-30 |
EP0295721A3 (en) | 1989-02-01 |
KR890000101A (ko) | 1989-03-11 |
AU1811788A (en) | 1988-12-22 |
DE3867328D1 (de) | 1992-02-13 |
KR910005886B1 (ko) | 1991-08-06 |
DK333788D0 (da) | 1988-06-17 |
JPH0311785B2 (es) | 1991-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2027728T3 (es) | Procedimiento para hacer un injerto que se ha de usar para actila cicatrizacion de un tejido. | |
ES2034053T3 (es) | Agentes conferidores de consistencia solubles en agua. | |
JPS6434361A (en) | Kit used in treatment of femur disorder | |
SE8803486D0 (sv) | Dosage form for treating cardiovascular diseases | |
ATE194272T1 (de) | Intraokulare prothese | |
FI946004A0 (fi) | Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio | |
ES2059537T3 (es) | Metodo para purgar in vitro celulas tumorales residuales con la ayuda de celulas citotoxicas activadas por una linfocina. | |
ES2069219T3 (es) | Formulacion adhesiva para mejorar la regeneracion de nervios lesionados y formulacion farmaceutica adhesiva correspondiente. | |
LU91125I2 (fr) | Ranélate den strontium et ses dérivés pharmaceutiquement acceptables (protelos). | |
ES2031924T3 (es) | Implantacion osea. | |
ES2053458T3 (es) | Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma. | |
ES2179096T3 (es) | Utilizacion de la interleucina-12 para prevenir la reaccion del injerto contra el huesped. | |
AR022404A1 (es) | Metodo y agentes para la terapia de radiacion mejorada | |
ES2140430T3 (es) | Procedimiento para aumentar el brillo del cabello y para reparar el cabello dañado por productos alcalinos. | |
SG30591G (en) | Use of azelastin and glycerine ethers for the treatment of psoriasis | |
ATE343983T1 (de) | Ophthalmologisches implantat | |
SE8604757L (sv) | Intraalveolert implantat | |
SE8700969D0 (sv) | Resorberbar protes | |
MX9301192A (es) | Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped. | |
MX170326B (es) | Cabello artificial para la implantacion de cabellos y procedimiento y aparato para su produccion | |
ES2150902T3 (es) | Procedimientos para potenciar la cicatrizacion de heridas y la reparacion de tejidos. | |
ES520218A0 (es) | Un procedimiento para la preparacion de nuevos 2,3-diaril-5-halotiofenos. | |
MX9206135A (es) | Metodos | |
ES2191206T3 (es) | Nueva utilizacion de la creatina. | |
DE69937892D1 (de) | Implantatmaterial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 295721 Country of ref document: ES |